What is TB-500/BPC-157 5/5mg
TB-500 (a thymosin β4–derived peptide) combined with BPC-157 (a gastric pentadecapeptide) is a research blend investigated for coordinated effects on cellular repair, angiogenic signaling, and connective-tissue remodeling in controlled laboratory models.
Potential Research Effects
• Collagen synthesis and extracellular-matrix remodeling studies
• Angiogenesis, cellular migration, and wound-closure kinetics
• Tendon/ligament and musculoskeletal recovery paradigms
• Inflammation-resolution and cytoprotective pathway exploration
• Gastroprotective and endothelial integrity modeling
Includes 10 sterile research-use syringes with every vial order.
Cybergen Peptides: Research Use Disclaimer
All products offered by Cybergen Peptides are intended solely for laboratory, educational, and scientific research purposes.
These materials are supplied for in-vitro research only (“in glass”) and are
not intended for human or animal consumption, medical use, or diagnostic applications.
Cybergen Peptides compounds are not drugs, medicines, or dietary supplements and have
not been evaluated or approved by the U.S. Food and Drug Administration (FDA) or any other regulatory agency.
They are not intended to diagnose, treat, cure, or prevent any disease.
Any form of bodily introduction, clinical testing, or therapeutic application is strictly prohibited.
